(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
7 Powerful Techniques to Boost Efficiency with Your Cell Phone: A Thorough Aide - 2AstraZeneca to invest $2 billion as part of US manufacturing push
- 3A Gustav Klimt painting is now the most expensive piece of modern art sold at auction. The fascinating history behind the $236 million 'Portrait of Elisabeth Lederer.'
- 4Israeli strikes on Beirut, as Hezbollah and Iran attack Israel
- 5Environmental groups urge Germany to cut oil and gas dependence
- Instructions to Perform Fundamental Upkeep on Your Slam 1500.
- Falcon 9 rocket launches Starlink satellites before making 550th SpaceX landing (video)
- 'Wicked: For Good' was filmed at this surreal National Park in Egypt
- Figure out How to Modify Your Pre-assembled Home for Greatest Solace and Stylish Allure
- Study reveals links between global food systems, obesity, and climate change
- UNICEF: More than 100 children killed in Gaza since ceasefire
- Central African Republic's president sworn in for a third term after disputed election
- The Best Computer games Ever
- Savvy Watches: Which One Is Appropriate for You?
